McKesson Share Holder Equity 2010-2022 | MCK

McKesson share holder equity from 2010 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
  • McKesson share holder equity for the quarter ending June 30, 2022 was $-1.472B, a 3171.11% increase year-over-year.
  • McKesson share holder equity for 2022 was $-1.792B, a 1124% decline from 2021.
  • McKesson share holder equity for 2021 was $0.175B, a 96.7% decline from 2020.
  • McKesson share holder equity for 2020 was $5.309B, a 35.94% decline from 2019.
McKesson Annual Share Holder Equity
(Millions of US $)
2022 $-1,792
2021 $175
2020 $5,309
2019 $8,287
2018 $10,057
2017 $11,273
2016 $9,008
2015 $8,085
2014 $10,318
2013 $7,070
2012 $6,831
2011 $7,220
2010 $7,532
2009 $6,193
McKesson Quarterly Share Holder Equity
(Millions of US $)
2022-06-30 $-1,472
2022-03-31 $-1,792
2021-12-31 $-787
2021-09-30 $-87
2021-06-30 $-45
2021-03-31 $175
2020-12-31 $-277
2020-09-30 $6,090
2020-06-30 $5,653
2020-03-31 $5,309
2019-12-31 $6,385
2019-09-30 $6,692
2019-06-30 $8,068
2019-03-31 $8,287
2018-12-31 $9,389
2018-09-30 $9,534
2018-06-30 $9,647
2018-03-31 $10,057
2017-12-31 $11,972
2017-09-30 $11,362
2017-06-30 $11,513
2017-03-31 $11,273
2016-12-31 $7,852
2016-09-30 $9,623
2016-06-30 $9,491
2016-03-31 $9,008
2015-12-31 $8,960
2015-09-30 $8,873
2015-06-30 $8,939
2015-03-31 $8,085
2014-12-31 $9,156
2014-09-30 $10,526
2014-06-30 $10,765
2014-03-31 $10,318
2013-12-31 $8,027
2013-09-30 $7,989
2013-06-30 $7,408
2013-03-31 $7,070
2012-12-31 $7,649
2012-09-30 $7,715
2012-06-30 $7,203
2012-03-31 $6,831
2011-12-31 $7,456
2011-09-30 $7,116
2011-06-30 $6,917
2011-03-31 $7,220
2010-12-31 $7,080
2010-09-30 $6,815
2010-06-30 $6,879
2010-03-31 $7,532
2009-12-31 $7,123
2009-09-30 $6,719
2009-06-30 $6,271
2009-03-31 $6,193
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $52.490B $263.966B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $75.203B 21.85
AmerisourceBergen (ABC) United States $31.524B 13.92
West Pharmaceutical Services (WST) United States $25.249B 38.44
Laboratory Of America Holdings (LH) United States $24.048B 10.52
Cardinal Health (CAH) United States $18.885B 13.70
Cooper (COO) United States $16.482B 25.37
CONMED (CNMD) United States $3.143B 30.98
Invacare (IVC) United States $0.036B 0.00